Gulle, S. Et Al. 2022. Efficacy and Safety of Secukinumab in the Treatment of Axial Spondyloarthritis: Real-Life Data from TURKBIO Cohort. ARTHRITIS & RHEUMATOLOGY , vol.74 , 843-845.

Gulle, S., Karakas, A., CAN, G., Senel, S., ÇAPAR, S., DALKILIÇ, H. E., ... AKAR, S.(2022). Efficacy and Safety of Secukinumab in the Treatment of Axial Spondyloarthritis: Real-Life Data from TURKBIO Cohort. ARTHRITIS & RHEUMATOLOGY , vol.74, 843-845.

Gulle, Semih Et Al. "Efficacy and Safety of Secukinumab in the Treatment of Axial Spondyloarthritis: Real-Life Data from TURKBIO Cohort," ARTHRITIS & RHEUMATOLOGY , vol.74, 843-845, 2022

Gulle, Semih Et Al. "Efficacy and Safety of Secukinumab in the Treatment of Axial Spondyloarthritis: Real-Life Data from TURKBIO Cohort." ARTHRITIS & RHEUMATOLOGY , vol.74, pp.843-845, 2022

Gulle, S. Et Al. (2022) . "Efficacy and Safety of Secukinumab in the Treatment of Axial Spondyloarthritis: Real-Life Data from TURKBIO Cohort." ARTHRITIS & RHEUMATOLOGY , vol.74, pp.843-845.

@article{article, author={Semih Gulle Et Al. }, title={Efficacy and Safety of Secukinumab in the Treatment of Axial Spondyloarthritis: Real-Life Data from TURKBIO Cohort}, journal={ARTHRITIS & RHEUMATOLOGY}, year=2022, pages={843-845} }